Zimmer Biomet director granted phantom stock units

Kolli Sreelakshmi reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kolli Sreelakshmi reported acquisition or exercise transactions in this Form 4 filing.

Zimmer Biomet Holdings director Kolli Sreelakshmi received a grant of phantom stock units as director compensation. On March 31, 2026, she was awarded 175.404 phantom stock units under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors, tied 1-for-1 to common stock. These units are to be settled in shares of company common stock within sixty days after she ceases serving as a director. Following this award and prior dividend reinvestments, she now holds a total of 5,769.994 phantom stock units, including 15.067 units accrued on January 30, 2026 through the plan’s dividend reinvestment provision.

Insider Trade Summary

Grant/Award: 175.404 shares

Grant/Award 1 txn

Insider Kolli Sreelakshmi

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	175.404	$0.00	$0.00

Holdings After Transaction: Phantom Stock Units — 5,769.994 contracts (Direct)

Footnotes (4)

1. F1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
2. F2. The Conversion or Exercise Price of Derivative Security is 1-for-1
3. F3. Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
4. F4. Includes 15.067 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Key Figures

Phantom stock units granted: 175.404 units Total phantom units after grant: 5,769.994 units Dividend reinvestment accrual: 15.067 units +2 more

5 metrics

Phantom stock units granted 175.404 units Grant on March 31, 2026 to director Kolli Sreelakshmi

Total phantom units after grant 5,769.994 units Director’s holdings following March 31, 2026 award

Dividend reinvestment accrual 15.067 units Accrued on January 30, 2026 via dividend reinvestment

Conversion ratio 1-for-1 Each phantom stock unit tied to one share of common stock

Settlement window within 60 days Units settled in common stock after director’s service ends

Key Terms

Phantom Stock Units, Deferred Compensation Plan for Non-Employee Directors, dividend reinvestment provision, phantom stock units

4 terms

Phantom Stock Units financial

"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Deferred Compensation Plan for Non-Employee Directors financial

"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

dividend reinvestment provision financial

"Includes 15.067 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

A dividend reinvestment provision is a company policy that lets shareholders automatically use their cash dividends to buy more shares instead of receiving money. Think of it like a subscription that turns each payday into buying an extra slice of the same pie; it helps investors compound their holdings over time, often with lower transaction costs and sometimes at a small discount, which can boost long‑term returns and subtly change ownership percentages.

phantom stock units financial

"Includes 15.067 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision..."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

FAQ

What insider transaction did Zimmer Biomet (ZBH) report for Kolli Sreelakshmi?

Zimmer Biomet reported that director Kolli Sreelakshmi received 175.404 phantom stock units on March 31, 2026. These units were granted under the company’s Deferred Compensation Plan for Non-Employee Directors and represent a form of equity-based director compensation.

How many phantom stock units does Zimmer Biomet (ZBH) director Kolli Sreelakshmi hold after this Form 4?

After the March 31, 2026 grant, Kolli Sreelakshmi holds 5,769.994 phantom stock units. This total includes the new 175.404-unit award and 15.067 units accrued on January 30, 2026 through the plan’s dividend reinvestment provision.

What are phantom stock units in the Zimmer Biomet (ZBH) director compensation plan?

Phantom stock units in this plan are bookkeeping units accrued under the Deferred Compensation Plan for Non-Employee Directors. They are tied 1-for-1 to Zimmer Biomet common stock and are ultimately settled in actual shares of company common stock, rather than cash.

When will Zimmer Biomet (ZBH) settle these phantom stock units for Kolli Sreelakshmi?

The phantom stock units are scheduled to be settled in shares of Zimmer Biomet common stock within sixty days after Kolli Sreelakshmi’s service as a director ends. Settlement timing is therefore linked to the cessation of her board service, not to a fixed calendar date.

How were additional Zimmer Biomet (ZBH) phantom stock units accrued for Kolli Sreelakshmi?

An additional 15.067 phantom stock units were accrued on January 30, 2026 under the plan’s dividend reinvestment provision. This means dividends associated with the underlying common stock were reinvested into more phantom units, increasing her deferred equity-based position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kolli Sreelakshmi

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW INDIANA 46580

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units(1)	$89.08(2)	03/31/2026		A		175.404		(3)	(3)	Common Stock	175.404	$0	5,769.994(4)	D

Explanation of Responses:

1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

2. The Conversion or Exercise Price of Derivative Security is 1-for-1

3. Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

4. Includes 15.067 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Sreelakshmi Kolli (power of attorney previously filed)	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)